Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Үндсэн зохиолчид: | Church, D, Midgley, R, Kerr, D |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2012
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
-н: Midgley, R, зэрэг
Хэвлэсэн: (2005) -
The emergence of 'omics for the management of colorectal cancer.
-н: Midgley, R, зэрэг
Хэвлэсэн: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
-н: Midgley, R, зэрэг
Хэвлэсэн: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
-н: Joao Paulo Solar Vasconcelos, зэрэг
Хэвлэсэн: (2022-12-01) -
Immunotherapy for colorectal cancer.
-н: Midgley, R, зэрэг
Хэвлэсэн: (2003)